Global Apatinib Mesylate Production, Demand and Key Producers, 2022-2028

November 2022 | 75 pages | ID: G1ED3E926797EN
GlobalInfoResearch

Abstracts

Drugs for the treatment of third-line or above patients with advanced gastric adenocarcinoma or gastric-esophageal junction adenocarcinoma

This report studies the global Apatinib Mesylate production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Apatinib Mesylate, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Apatinib Mesylate that contribute to its increasing demand across many markets.

The global Apatinib Mesylate market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Apatinib Mesylate total production and demand, 2017-2028, (Kg)

Global Apatinib Mesylate total production value, 2017-2028, (USD Million)

Global Apatinib Mesylate production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Kg)

Global Apatinib Mesylate consumption by region & country, CAGR, 2017-2028 & (Kg)

U.S. VS China: Apatinib Mesylate domestic production, consumption, key domestic manufacturers and share

Global Apatinib Mesylate production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Kg)

Global Apatinib Mesylate production by Dosage Strength, production, value, CAGR, 2017-2028, (USD Million) & (Kg)

Global Apatinib Mesylate production by Application production, value, CAGR, 2017-2028, (USD Million) & (Kg)

This reports profiles key players in the global Apatinib Mesylate market based on the following parameters – headquarters, production locations, products portfolio, Apatinib Mesylate revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Apatinib Mesylate market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Kg) and average price (US$/Kg) by manufacturer, by Dosage Strength, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Apatinib Mesylate Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India

Global Apatinib Mesylate Market, Segmentation by Dosage Strength

• 0.375G
• 0.425G

Global Apatinib Mesylate Market, Segmentation by Application

• Advanced Gastric Adenocarcinoma
• Gastric-esophageal Junction Adenocarcinoma

Companies Profiled:

• Fuslai
• Tianyu Pharma
• Hengrui

Key Questions Answered

1. How big is the global Apatinib Mesylate market?

2. What is the demand of the global Apatinib Mesylate market?

3. What is the year over year growth of the global Apatinib Mesylate market?

4. What is the production and production value of the global Apatinib Mesylate market?

5. Who are the key producers in the global Apatinib Mesylate market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Apatinib Mesylate Introduction
1.2 World Apatinib Mesylate Supply & Forecast
  1.2.1 World Apatinib Mesylate Production Value (2017 & 2021 & 2028)
  1.2.2 World Apatinib Mesylate Production (2017-2028)
  1.2.3 World Apatinib Mesylate Pricing Trends (2017-2028)
1.3 World Apatinib Mesylate Production by Region
  1.3.1 World Apatinib Mesylate Production Value by Region (2017-2028)
  1.3.2 World Apatinib Mesylate Production by Region (2017-2028)
  1.3.3 World Apatinib Mesylate Average Price by Region (2017-2028)
  1.3.4 North America Apatinib Mesylate Production (2017-2028)
  1.3.5 Europe Apatinib Mesylate Production (2017-2028)
  1.3.6 China Apatinib Mesylate Production (2017-2028)
  1.3.7 Japan Apatinib Mesylate Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Apatinib Mesylate Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Apatinib Mesylate Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Apatinib Mesylate Demand (2017-2028)
2.2 World Apatinib Mesylate Consumption by Region
  2.2.1 World Apatinib Mesylate Consumption by Region (2017-2022)
  2.2.2 World Apatinib Mesylate Consumption Forecast by Region (2023-2028)
2.3 United States Apatinib Mesylate Consumption (2017-2028)
2.4 China Apatinib Mesylate Consumption (2017-2028)
2.5 Europe Apatinib Mesylate Consumption (2017-2028)
2.6 Japan Apatinib Mesylate Consumption (2017-2028)
2.7 South Korea Apatinib Mesylate Consumption (2017-2028)
2.8 ASEAN Apatinib Mesylate Consumption (2017-2028)
2.9 India Apatinib Mesylate Consumption (2017-2028)

3 WORLD APATINIB MESYLATE MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Apatinib Mesylate Production Value by Manufacturer (2017-2022)
3.2 World Apatinib Mesylate Production by Manufacturer (2017-2022)
3.3 World Apatinib Mesylate Average Price by Manufacturer (2017-2022)
3.4 Apatinib Mesylate Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Apatinib Mesylate Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Apatinib Mesylate in 2021
  3.5.3 Global Concentration Ratios (CR8) for Apatinib Mesylate in 2021
3.6 Apatinib Mesylate Market: Overall Company Footprint Analysis
  3.6.1 Apatinib Mesylate Market: Region Footprint
  3.6.2 Apatinib Mesylate Market: Company Product Type Footprint
  3.6.3 Apatinib Mesylate Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Apatinib Mesylate Production Value Comparison
  4.1.1 United States VS China: Apatinib Mesylate Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Apatinib Mesylate Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Apatinib Mesylate Production Comparison
  4.2.1 United States VS China: Apatinib Mesylate Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Apatinib Mesylate Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Apatinib Mesylate Consumption Comparison
  4.3.1 United States VS China: Apatinib Mesylate Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Apatinib Mesylate Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Apatinib Mesylate Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Apatinib Mesylate in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022)
4.5 China Apatinib Mesylate Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Apatinib Mesylate in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Apatinib Mesylate Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Apatinib Mesylate in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY DOSAGE STRENGTH

5.1 World Apatinib Mesylate Market Size Overview by Dosage Strength: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Dosage Strength
  5.2.1 0.375G
  5.2.2 0.425G
5.3 Market Segment by Dosage Strength
  5.3.1 World Apatinib Mesylate Production by Dosage Strength (2017-2028)
  5.3.2 World Apatinib Mesylate Production Value by Dosage Strength (2017-2028)
  5.3.3 World Apatinib Mesylate Average Price by Dosage Strength (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Apatinib Mesylate Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Advanced Gastric Adenocarcinoma
  6.2.2 Gastric-esophageal Junction Adenocarcinoma
6.3 Market Segment by Application
  6.3.1 World Apatinib Mesylate Production by Application (2017-2028)
  6.3.2 World Apatinib Mesylate Production Value by Application (2017-2028)
  6.3.3 World Apatinib Mesylate Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Fuslai
  7.1.1 Fuslai Details
  7.1.2 Fuslai Major Business
  7.1.3 Fuslai Apatinib Mesylate Product and Services
  7.1.4 Fuslai Apatinib Mesylate Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Fuslai Recent Developments/Updates
  7.1.6 Fuslai Competitive Strengths & Weaknesses
7.2 Tianyu Pharma
  7.2.1 Tianyu Pharma Details
  7.2.2 Tianyu Pharma Major Business
  7.2.3 Tianyu Pharma Apatinib Mesylate Product and Services
  7.2.4 Tianyu Pharma Apatinib Mesylate Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 Tianyu Pharma Recent Developments/Updates
  7.2.6 Tianyu Pharma Competitive Strengths & Weaknesses
7.3 Hengrui
  7.3.1 Hengrui Details
  7.3.2 Hengrui Major Business
  7.3.3 Hengrui Apatinib Mesylate Product and Services
  7.3.4 Hengrui Apatinib Mesylate Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 Hengrui Recent Developments/Updates
  7.3.6 Hengrui Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Apatinib Mesylate and Key Manufacturers
8.2 Apatinib Mesylate Manufacturing Costs
8.3 Apatinib Mesylate Production Process
8.4 Apatinib Mesylate Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Apatinib Mesylate Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Apatinib Mesylate Typical Distributors
9.3 Apatinib Mesylate Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Apatinib Mesylate Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Apatinib Mesylate Production Value by Region (2017-2022) & (USD Million)
Table 3. World Apatinib Mesylate Production Value by Region (2023-2028) & (USD Million)
Table 4. World Apatinib Mesylate Production Value Market Share by Region (2017-2022)
Table 5. World Apatinib Mesylate Production Value Market Share by Region (2023-2028)
Table 6. World Apatinib Mesylate Production by Region (2017-2022) & (Kg)
Table 7. World Apatinib Mesylate Production by Region (2023-2028) & (Kg)
Table 8. World Apatinib Mesylate Production Market Share by Region (2017-2022)
Table 9. World Apatinib Mesylate Production Market Share by Region (2023-2028)
Table 10. World Apatinib Mesylate Average Price by Region (2017-2022) & (US$/Kg)
Table 11. World Apatinib Mesylate Average Price by Region (2023-2028) & (US$/Kg)
Table 12. Apatinib Mesylate Major Market Trends
Table 13. World Apatinib Mesylate Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Kg)
Table 14. World Apatinib Mesylate Consumption by Region (2017-2022) & (Kg)
Table 15. World Apatinib Mesylate Consumption Forecast by Region (2023-2028) & (Kg)
Table 16. World Apatinib Mesylate Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Apatinib Mesylate Producers in 2021
Table 18. World Apatinib Mesylate Production by Manufacturer (2017-2022) & (Kg)
Table 19. Production Market Share of Key Apatinib Mesylate Producers in 2021
Table 20. World Apatinib Mesylate Average Price by Manufacturer (2017-2022) & (US$/Kg)
Table 21. Global Apatinib Mesylate Company Evaluation Quadrant
Table 22. World Apatinib Mesylate Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Apatinib Mesylate Production Site of Key Manufacturer
Table 24. Apatinib Mesylate Market: Company Product Type Footprint
Table 25. Apatinib Mesylate Market: Company Product Application Footprint
Table 26. Apatinib Mesylate Competitive Factors
Table 27. Apatinib Mesylate New Entrant and Capacity Expansion Plans
Table 28. Apatinib Mesylate Mergers & Acquisitions Activity
Table 29. United States VS China Apatinib Mesylate Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Apatinib Mesylate Production Comparison, (2017 & 2021 & 2028) & (Kg)
Table 31. United States VS China Apatinib Mesylate Consumption Comparison, (2017 & 2021 & 2028) & (Kg)
Table 32. Major Manufacturer of Apatinib Mesylate in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Apatinib Mesylate Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022) & (Kg)
Table 36. United States Apatinib Mesylate Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Apatinib Mesylate in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Apatinib Mesylate Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022) & (Kg)
Table 41. China Apatinib Mesylate Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Apatinib Mesylate in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Apatinib Mesylate Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Apatinib Mesylate Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Apatinib Mesylate Production by Domestic Manufacturer, (2017-2022) & (Kg)
Table 46. Rest of World Apatinib Mesylate Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Apatinib Mesylate Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Table 48. World Apatinib Mesylate Production by Dosage Strength (2017-2022) & (Kg)
Table 49. World Apatinib Mesylate Production by Dosage Strength (2023-2028) & (Kg)
Table 50. World Apatinib Mesylate Production Value by Dosage Strength (2017-2022) & (USD Million)
Table 51. World Apatinib Mesylate Production Value by Dosage Strength (2023-2028) & (USD Million)
Table 52. World Apatinib Mesylate Average Price by Dosage Strength (2017-2022) & (US$/Kg)
Table 53. World Apatinib Mesylate Average Price by Dosage Strength (2023-2028) & (US$/Kg)
Table 54. World Apatinib Mesylate Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Apatinib Mesylate Production by Application (2017-2022) & (Kg)
Table 56. World Apatinib Mesylate Production by Application (2023-2028) & (Kg)
Table 57. World Apatinib Mesylate Production Value by Application (2017-2022) & (USD Million)
Table 58. World Apatinib Mesylate Production Value by Application (2023-2028) & (USD Million)
Table 59. World Apatinib Mesylate Average Price by Application (2017-2022) & (US$/Kg)
Table 60. World Apatinib Mesylate Average Price by Application (2023-2028) & (US$/Kg)
Table 61. Fuslai Basic Information, Manufacturing Base and Competitors
Table 62. Fuslai Major Business
Table 63. Fuslai Apatinib Mesylate Product and Services
Table 64. Fuslai Apatinib Mesylate Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Fuslai Recent Developments/Updates
Table 66. Fuslai Competitive Strengths & Weaknesses
Table 67. Tianyu Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Tianyu Pharma Major Business
Table 69. Tianyu Pharma Apatinib Mesylate Product and Services
Table 70. Tianyu Pharma Apatinib Mesylate Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Tianyu Pharma Recent Developments/Updates
Table 72. Hengrui Basic Information, Manufacturing Base and Competitors
Table 73. Hengrui Major Business
Table 74. Hengrui Apatinib Mesylate Product and Services
Table 75. Hengrui Apatinib Mesylate Production (Kg), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 76. Apatinib Mesylate Raw Material
Table 77. Key Manufacturers of Apatinib Mesylate Raw Materials
Table 78. Apatinib Mesylate Typical Distributors
Table 79. Apatinib Mesylate Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Apatinib Mesylate Picture
Figure 2. World Apatinib Mesylate Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Apatinib Mesylate Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Apatinib Mesylate Production (2017-2028) & (Kg)
Figure 5. World Apatinib Mesylate Average Price (2017-2028) & (US$/Kg)
Figure 6. World Apatinib Mesylate Production Value Market Share by Region (2017-2028)
Figure 7. World Apatinib Mesylate Production Market Share by Region (2017-2028)
Figure 8. North America Apatinib Mesylate Production (2017-2028) & (Kg)
Figure 9. Europe Apatinib Mesylate Production (2017-2028) & (Kg)
Figure 10. China Apatinib Mesylate Production (2017-2028) & (Kg)
Figure 11. Japan Apatinib Mesylate Production (2017-2028) & (Kg)
Figure 12. Apatinib Mesylate Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Apatinib Mesylate Demand (2017-2028) & (Kg)
Figure 15. World Apatinib Mesylate Consumption Market Share by Region (2017-2028)
Figure 16. United States Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 17. China Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 18. Europe Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 19. Japan Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 20. South Korea Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 21. ASEAN Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 22. India Apatinib Mesylate Consumption (2017-2028) & (Kg)
Figure 23. Producer Shipments of Apatinib Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Apatinib Mesylate Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Apatinib Mesylate Markets in 2021
Figure 26. United States VS China: Apatinib Mesylate Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Apatinib Mesylate Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Apatinib Mesylate Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Apatinib Mesylate in United States
Figure 30. Key Producers and Market Share of Apatinib Mesylate in China
Figure 31. Key Producers and Market Share of Apatinib Mesylate in Rest of World
Figure 32. World Apatinib Mesylate Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Figure 33. World Apatinib Mesylate Production Value Market Share by Dosage Strength in 2021
Figure 34. 0.375G
Figure 35. 0.425G
Figure 36. World Apatinib Mesylate Production Market Share by Dosage Strength (2017-2028)
Figure 37. World Apatinib Mesylate Production Value Market Share by Dosage Strength (2017-2028)
Figure 38. World Apatinib Mesylate Average Price by Dosage Strength (2017-2028) & (US$/Kg)
Figure 39. World Apatinib Mesylate Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Apatinib Mesylate Production Value Market Share by Application in 2021
Figure 41. Advanced Gastric Adenocarcinoma
Figure 42. Gastric-esophageal Junction Adenocarcinoma
Figure 43. World Apatinib Mesylate Production Market Share by Application (2017-2028)
Figure 44. World Apatinib Mesylate Production Value Market Share by Application (2017-2028)
Figure 45. World Apatinib Mesylate Average Price by Application (2017-2028) & (US$/Kg)
Figure 46. Manufacturing Cost Structure Analysis of Apatinib Mesylate in 2021
Figure 47. Manufacturing Process Analysis of Apatinib Mesylate
Figure 48. Apatinib Mesylate Industrial Chain
Figure 49. Distribution Channel Breakdown for Apatinib Mesylate Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source